Hyperphosphatemia News, Research | High Phosphate Clinical Studies

Hyperphosphatemia

HYPERPHOSPHATEMIA

VDRAs Do Not Lower Cardiovascular Event Risk in HD

Trial results do not support use of vitamin D receptor activators to prevent cardiovascular events in patients with end-stage renal disease and low intact parathyroid hormone levels.
Next post in Hyperphosphatemia